Efficacy of Hylan G-F 20 and Sodium Hyaluronate in the treatment of osteoarthritis of the knee - A prospective randomized clinical trial

Knee

Volumn 15, Issue 4, 2008, Pages 318-324

  Raman, R ^a   Dutta, A ^a   Day, N ^a   Sharma, H K ^a   Shaw, C J ^a   Johnson, G V ^a  

^a HULL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Hyaluronic acid; Knee; Osteoarthritis; Randomized; Viscosupplementation

Indexed keywords

HYALURONIC ACID; HYLAN G F 20;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; KNEE OSTEOARTHRITIS; KNEE PAIN; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VISCOSITY;

ADJUVANTS, IMMUNOLOGIC; BIOCOMPATIBLE MATERIALS; FOLLOW-UP STUDIES; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PATIENT SATISFACTION; PROSPECTIVE STUDIES; RANGE OF MOTION, ARTICULAR; RECOVERY OF FUNCTION; TREATMENT OUTCOME;

EID: 45849116231     PISSN: 09680160     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.knee.2008.02.012     Document Type: Article

References (59)

1. Felson D.T. An update on the pathogenesis and epidemiology of osteoarthritis. Radiol Clin North Am 42 1 (2004) 1-9
2. Garstang S.V., and Stitik T.P. Osteoarthritis: epidemiology, risk factors, and pathophysiology. Am J Phys Med Rehabil 85 11 Suppl (2006) S2-S14
3. Balazs E.A., Watson D., Duff I.F., and Roseman S. Hyaluronic acid in synovial fluid. I. Molecular parameters of hyaluronic acid in normal and arthritis human fluids. Arthritis Rheum 10 4 (1967) 357-376
4. Gibbs D.A., Merrill E.W., Smith K.A., and Balazs E.A. Rheology of hyaluronic acid. Biopolymers 6 6 (1968) 777-791
5. Wright K.E., Maurer S.G., and Di Cesare P.E. Viscosupplementation for osteoarthritis. Am J Orthop 29 2 (2000) 80-89
6. Pelletier J.P., and Martel-Pelletier J. The pathophysiology of osteoarthritis and the implication of the use of hyaluronan and hylan as therapeutic agents in viscosupplementation. J Rheumatol Suppl 39 (1993) 19-24
7. Balazs E.A., and Denlinger J.L. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol, Suppl 39 (1993) 3-9
8. Peyron J.G. A new approach to the treatment of osteoarthritis: viscosupplementation. Osteoarthritis Cartilage 1 2 (1993) 85-87
9. Simon L.S. Viscosupplementation therapy with intra-articular hyaluronic acid. Fact or fantasy?. Rheum Dis Clin North Am 25 2 (1999) 345-357
10. Wang C.T., Lin J., Chang C.J., Lin Y.T., and Hou S.M. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Jt Surg Am 86-A 3 (2004) 538-545
11. Waddell D.D., and Bricker D.C. Hylan G-F 20 tolerability with repeat treatment in a large orthopedic practice: a retrospective review. J Surg Orthop Adv 15 1 (2006) 53-59
12. Waddell D.D. The tolerability of viscosupplementation: low incidence and clinical management of local adverse events. Curr Med Res Opin 19 7 (2003) 575-580
13. George E. Intra-articular hyaluronan treatment for osteoarthritis. Ann Rheum Dis 57 11 (1998) 637-640
14. Balazs E.A. Viscosupplementation for treatment of osteoarthritis: from initial discovery to current status and results. Surg Technol Int 12 (2004) 278-289
15. Adams M.E., Lussier A.J., and Peyron J.G. A risk-benefit assessment of injections of hyaluronan and its derivatives in the treatment of osteoarthritis of the knee. Drug Safety 23 2 (2000) 115-130
16. Kirwan J. Is there a place for intra-articular hyaluronate in osteoarthritis of the knee?. Knee 8 2 (2001) 93-101
17. Bellamy N., Campbell J., Robinson V., Gee T., Bourne R., and Wells G. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2 (2006) CD005321
18. Watterson J.R., and Esdaile J.M. Viscosupplementation: therapeutic mechanisms and clinical potential in osteoarthritis of the knee. J Am Acad Orthop Surg 8 5 (2000) 277-284
19. Moreland L.W. Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Res Ther 5 2 (2003) 54-67
20. Wobig M., Bach G., Beks P., Dickhut A., Runzheimer J., Schwieger G., et al. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan. Clin Ther 21 9 (1999) 1549-1562
21. Allard S., and O'Regan M. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan. Clin Ther 22 6 (2000) 792-795
22. Altman R.D., Akermark C., Beaulieu A.D., and Schnitzer T. Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee. Osteoarthritis Cartilage 12 8 (2004) 642-649
23. Altman R.D., and Moskowitz R. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. J Rheumatol 25 11 (1998) 2203-2212
24. Henderson E.B., Smith E.C., Pegley F., and Blake D.R. Intra-articular injections of 750 kD hyaluronan in the treatment of osteoarthritis: a randomised single centre double-blind placebo-controlled trial of 91 patients demonstrating lack of efficacy. Ann Rheum Dis 53 8 (1994) 529-534
25. Kotevoglu N., Iyibozkurt P.C., Hiz O., Toktas H., and Kuran B. A prospective randomised controlled clinical trial comparing the efficacy of different molecular weight hyaluronan solutions in the treatment of knee osteoarthritis. Rheumatol Int 26 4 (2006) 325-330
26. Schiavinato A., Finesso M., Cortivo R., and Abatangelo G. Comparison of the effects of intra-articular injections of Hyaluronan and its chemically cross-linked derivative (Hylan G-F20) in normal rabbit knee joints. Clin Exp Rheumatol 20 4 (2002) 445-454
27. Wobig M., Dickhut A., Maier R., and Vetter G. Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther 20 3 (1998) 410-423
28. Waddell D.D., and Bricker D.C. Clinical experience with the effectiveness and tolerability of hylan G-F 20 in 1047 patients with osteoarthritis of the knee. J Knee Surg 19 1 (2006) 19-27
29. Lee S., Park D., and Chmell S.J. Viscosupplementation with hylan G-F 20 (Synvisc): pain and mobility observations from 74 consecutive patients. J Knee Surg 17 2 (2004) 73-77
30. Dagenais S. Intra-articular hyaluronic acid (viscosupplementation) for knee osteoarthritis. Issues Emerg Health Technol 94 (2006) 1-4
31. Bunyaratavej N., Chan K.M., and Subramanian N. Treatment of painful osteoarthritis of the knee with hyaluronic acid. Results of a multicenter Asian study. J Med Assoc Thai 84 Suppl 2 (2001) S576-S581
32. Altman R.D., and Moskowitz R. A randomized clinical trial of intra-articular sodium hyaluronate in patients with osteoarthritis of the knee: a summary. Am J Orthop 28 11 Suppl (1999) 3-4
33. Adams M.E., Atkinson M.H., Lussier A.J., Schulz J.I., Siminovitch K.A., Wade J.P., et al. The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis Cartilage 3 4 (1995) 213-225
34. Kellgren J.H., and Lawrence J.S. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16 4 (1957) 494-502
35. Bellamy N., Buchanan W.W., Goldsmith C.H., Campbell J., and Stitt L.W. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15 12 (1988) 1833-1840
36. Bellamy N. WOMAC: a 20-year experiential review of a patient-centered self-reported health status questionnaire. J Rheumatol 29 12 (2002) 2473-2476
37. Dawson J., Fitzpatrick R., Murray D., and Carr A. Questionnaire on the perceptions of patients about total knee replacement. J Bone Jt Surg Br 80 1 (1998) 63-69
38. Kind P., and Gudex C.M. Measuring health status in the community: a comparison of methods. J Epidemiol Community Health 48 1 (1994) 86-91
39. Brazier J., Jones N., and Kind P. Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire. Qual Life Res 2 3 (1993) 169-180
40. Williams A. The measurement and valuation of health: a chronicle. Discussion paper136. Centre for Health Economics: University of York, 1995.
41. American Academy of Orthopedic Surgeons. Knee osteoarthritis - phase II. 2003.
42. Recommendations for the medical management of osteoarthritis of the hip and knee - American College of rheumatology subcommittee on osteoarthritis guidelines. Arthritis Rheum 43 9 (2000) 1905-1915
43. Forster M.C., and Straw R. A prospective randomised trial comparing intra-articular Hyalgan injection and arthroscopic washout for knee osteoarthritis. Knee 10 3 (2003) 291-293
44. Clarke S., Lock V., Duddy J., Sharif M., Newman J.H., and Kirwan J.R. Intra-articular hylan G-F 20 (Synvisc) in the management of patellofemoral osteoarthritis of the knee (POAK). Knee 12 1 (2005) 57-62
45. Adams M.E. An analysis of clinical studies of the use of crosslinked hyaluronan, hylan, in the treatment of osteoarthritis. J Rheumatol Suppl 39 (1993) 16-18
46. Torrance G.W., Raynauld J.P., Walker V., Goldsmith C.H., Bellamy N., Band P.A., et al. A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic results. Osteoarthritis Cartilage 10 7 (2002) 518-527
47. Raynauld J.P., Torrance G.W., Band P.A., Goldsmith C.H., Tugwell P., Walker V., et al. A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results. Osteoarthritis Cartilage 10 7 (2002) 506-517
48. Kolarz G., Kotz R., and Hochmayer I. Long-term benefits and repeated treatment cycles of intra-articular sodium hyaluronate (Hyalgan) in patients with osteoarthritis of the knee. Semin Arthritis Rheum 32 5 (2003) 310-319
49. Lohmander L.S., Dalen N., Englund G., Hamalainen M., Jensen E.M., Karlsson K., et al. Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. Hyaluronan Multicentre Trial Group. Ann Rheum Dis 55 7 (1996) 424-431
50. Toh E.M., Prasad P.S., and Teanby D. Correlating the efficacy of knee viscosupplementation with osteoarthritic changes on roentgenological examination. Knee 9 4 (2002) 321-330
51. Kemper F., Gebhardt U., Meng T., and Murray C. Tolerability and short-term effectiveness of hylan G-F 20 in 4253 patients with osteoarthritis of the knee in clinical practice. Curr Med Res Opin 21 8 (2005) 1261-1269
52. Bagga H., Burkhardt D., Sambrook P., and March L. Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee. J Rheumatol 33 5 (2006) 946-950
53. Goldberg V.M., and Buckwalter J.A. Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activity. Osteoarthritis Cartilage 13 3 (2005) 216-224
54. Puttick M.P., Wade J.P., Chalmers A., Connell D.G., and Rangno K.K. Acute local reactions after intraarticular hylan for osteoarthritis of the knee. J Rheumatol 22 7 (1995) 1311-1314
55. Martens P.B. Bilateral symmetric inflammatory reaction to hylan G-F 20 injection. Arthritis Rheum 44 4 (2001) 978-979
56. Leopold S.S., Warme W.J., Pettis P.D., and Shott S. Increased frequency of acute local reaction to intra-articular hylan GF-20 (synvisc) in patients receiving more than one course of treatment. J Bone Jt Surg Am 84-A 9 (2002) 1619-1623
57. Magilavy D., Polisson R., and Murray C. Acute local reaction to intra-articular Hylan G-F 20 (Synvisc): part I. J Bone Jt Surg, Am 85-A 8 (2003) 1618-1620
58. Pullman-Mooar S., Mooar P., Sieck M., Clayburne G., and Schumacher H.R. Are there distinctive inflammatory flares after hylan g-f 20 intraarticular injections?. J Rheumatol 29 12 (2002) 2611-2614
59. Marino A.A., Waddell D.D., Kolomytkin O.V., Pruett S., Sadasivan K.K., and Albright J.A. Assessment of immunologic mechanisms for flare reactions to Synvisc. Clin Orthop Relat Res 442 (2006) 187-194